While it isn’t clear which technologies are selected for assessment there are some pointers. If you can answer yes to the following questions then it may be time to alert NICE to your technology?

Is it new and is it novel?

Of course it is otherwise why would you have launched it!

Is there a strong body of clinical evidence

High-quality scientific evidence will increase the likelihood of a technology being selected for evaluation. Does the body of evidence you have collected meet this threshold or do you need to improve or modify the publication strategy.

Is there economic evidence

Are the costs well described?  Are these placed alongside the benefits or effectiveness delivered and is the model compatible with operation within the NHS.

Is it or could it be of significance to the NHS

Is the number of patients large enough to justify the process or is there a patient group – for example a minority - which are not covered by current treatment or diagnostic algorithms. How is the condition currently managed in the NHS?

Has NICE assessed something similar in the past

With limited capability – NICE assesses around 6 technologies each year – it less interested in revisiting old ground.  Have you reviewed past submissions?

Has the discipline been over represented

NICE needs to give everyone a look in.  It is probably not a good idea to put a technology forward in a discipline in which recent appraisals have taken place. Have you reviewed current and past topics?


NICE will compile a briefing note from information which you supply and from other inputs and the Medical Technology Advisory Committee will decide whether a full appraisal should be undertaken.
If successful NICE will produce a scope which outlines the evidence which they are looking for and areas which do not need to be included.  They will also appoint an assessment centre whose job it is to assess the evidence which you will provide.